212 related articles for article (PubMed ID: 17436279)
1. Expression profile of Papss2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo.
Stelzer C; Brimmer A; Hermanns P; Zabel B; Dietz UH
Dev Dyn; 2007 May; 236(5):1313-8. PubMed ID: 17436279
[TBL] [Abstract][Full Text] [Related]
2. Human 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency.
Venkatachalam KV
IUBMB Life; 2003 Jan; 55(1):1-11. PubMed ID: 12716056
[TBL] [Abstract][Full Text] [Related]
3. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization.
Xu ZH; Otterness DM; Freimuth RR; Carlini EJ; Wood TC; Mitchell S; Moon E; Kim UJ; Xu JP; Siciliano MJ; Weinshilboum RM
Biochem Biophys Res Commun; 2000 Feb; 268(2):437-44. PubMed ID: 10679223
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and ontogeny of sulfotransferase enzymes in mice.
Alnouti Y; Klaassen CD
Toxicol Sci; 2006 Oct; 93(2):242-55. PubMed ID: 16807285
[TBL] [Abstract][Full Text] [Related]
5. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase: radiochemical enzymatic assay, biochemical properties, and hepatic variation.
Xu Z; Wood TC; Adjei AA; Weinshilboum RM
Drug Metab Dispos; 2001 Feb; 29(2):172-8. PubMed ID: 11159808
[TBL] [Abstract][Full Text] [Related]
6. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes.
Xu ZH; Freimuth RR; Eckloff B; Wieben E; Weinshilboum RM
Pharmacogenetics; 2002 Jan; 12(1):11-21. PubMed ID: 11773860
[TBL] [Abstract][Full Text] [Related]
7. Under-sulfation by PAPS synthetase inhibition modulates the expression of ECM molecules during chondrogenesis.
Cho YR; Lee SJ; Jeon HB; Park ZY; Chun JS; Yoo YJ
Biochem Biophys Res Commun; 2004 Oct; 323(3):769-75. PubMed ID: 15381066
[TBL] [Abstract][Full Text] [Related]
8. Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1.
Mueller JW; Idkowiak J; Gesteira TF; Vallet C; Hardman R; van den Boom J; Dhir V; Knauer SK; Rosta E; Arlt W
J Biol Chem; 2018 Jun; 293(25):9724-9735. PubMed ID: 29743239
[TBL] [Abstract][Full Text] [Related]
9. Degenerative knee joint disease in mice lacking 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (Papss2) activity: a putative model of human PAPSS2 deficiency-associated arthrosis.
Ford-Hutchinson AF; Ali Z; Seerattan RA; Cooper DM; Hallgrímsson B; Salo PT; Jirik FR
Osteoarthritis Cartilage; 2005 May; 13(5):418-25. PubMed ID: 15882565
[TBL] [Abstract][Full Text] [Related]
10. Inactivating PAPSS2 mutations in a patient with premature pubarche.
Noordam C; Dhir V; McNelis JC; Schlereth F; Hanley NA; Krone N; Smeitink JA; Smeets R; Sweep FC; Claahsen-van der Grinten HL; Arlt W
N Engl J Med; 2009 May; 360(22):2310-8. PubMed ID: 19474428
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells.
Besset S; Vincourt JB; Amalric F; Girard JP
FASEB J; 2000 Feb; 14(2):345-54. PubMed ID: 10657990
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the substrate recognition mechanism of ATP-sulfurylase domain of human PAPS synthase 2.
Zhang P; Zhang L; Hou Z; Lin H; Gao H; Zhang L
Biochem Biophys Res Commun; 2022 Jan; 586():1-7. PubMed ID: 34818583
[TBL] [Abstract][Full Text] [Related]
13. Characterization and expression of human bifunctional 3'-phosphoadenosine 5'-phosphosulphate synthase isoforms.
Fuda H; Shimizu C; Lee YC; Akita H; Strott CA
Biochem J; 2002 Jul; 365(Pt 2):497-504. PubMed ID: 11931637
[TBL] [Abstract][Full Text] [Related]
14. 3'-Phosphoadenosine 5'-phosphosulfate (PAPS) synthases, naturally fragile enzymes specifically stabilized by nucleotide binding.
van den Boom J; Heider D; Martin SR; Pastore A; Mueller JW
J Biol Chem; 2012 May; 287(21):17645-17655. PubMed ID: 22451673
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1): gene resequencing, sequence variation, and functional genomics.
Xu ZH; Thomae BA; Eckloff BW; Wieben ED; Weinshilboum RM
Biochem Pharmacol; 2003 Jun; 65(11):1787-96. PubMed ID: 12781330
[TBL] [Abstract][Full Text] [Related]
16. Spatio-temporal distribution of chondromodulin-I mRNA in the chicken embryo: expression during cartilage development and formation of the heart and eye.
Dietz UH; Ziegelmeier G; Bittner K; Bruckner P; Balling R
Dev Dyn; 1999 Nov; 216(3):233-43. PubMed ID: 10590475
[TBL] [Abstract][Full Text] [Related]
17. Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression.
Vale-Cruz DS; Ma Q; Syme J; LuValle PA
Mech Dev; 2008; 125(9-10):843-56. PubMed ID: 18638549
[TBL] [Abstract][Full Text] [Related]
18. Clinical and radiographic features of the autosomal recessive form of brachyolmia caused by PAPSS2 mutations.
Iida A; Simsek-Kiper PÖ; Mizumoto S; Hoshino T; Elcioglu N; Horemuzova E; Geiberger S; Yesil G; Kayserili H; Utine GE; Boduroglu K; Watanabe S; Ohashi H; Alanay Y; Sugahara K; Nishimura G; Ikegawa S
Hum Mutat; 2013 Oct; 34(10):1381-6. PubMed ID: 23824674
[TBL] [Abstract][Full Text] [Related]
19. SOX9 protein is stabilized by TGF-β and regulates PAPSS2 mRNA expression in chondrocytes.
Chavez RD; Coricor G; Perez J; Seo HS; Serra R
Osteoarthritis Cartilage; 2017 Feb; 25(2):332-340. PubMed ID: 27746378
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the protein tyrosine phosphatase (PC12,Br7,Sl) gamma (-) isoform modulates chondrogenic patterning and growth.
Augustine KA; Rossi RM; Silbiger SM; Bucay N; Duryea D; Marshall WS; Medlock ES
Int J Dev Biol; 2000 Jun; 44(4):361-71. PubMed ID: 10949045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
